| Pharmacotherapy of Alzheimer’s disease: an overview of systematic reviews R Majidazar, E Rezazadeh-Gavgani, S Sadigh-Eteghad, A Naseri European journal of clinical pharmacology 78 (10), 1567-1587, 2022 | 40 | 2022 |
| Metformin: new applications for an old drug A Naseri, S Sanaie, S Hamzehzadeh, S Seyedi-Sahebari, MS Hosseini, ... Journal of Basic and Clinical Physiology and Pharmacology 34 (2), 151-160, 2023 | 31 | 2023 |
| Tumor‐derived exosomal PD‐L1 in progression of cancer and immunotherapy SZ Rasihashemi, E Rezazadeh Gavgani, R Majidazar, P Seraji, ... Journal of Cellular Physiology 237 (3), 1648-1660, 2022 | 14 | 2022 |
| Systematic review and meta-analysis of the most common genetic mutations in esophageal squamous cell carcinoma A Naseri, H Salehi-Pourmehr, R Majidazar, P Seraji, ... Journal of Gastrointestinal Cancer, 1-10, 2022 | 13 | 2022 |
| MicroRNA-21: A critical underestimated molecule in diabetic retinopathy E Rezazadeh-Gavgani, M Oladghaffari, S Bahramian, R Majidazar, ... Gene 859, 147212, 2023 | 11 | 2023 |
| Exosomes carrying immune checkpoints, a promising therapeutic approach in cancer treatment SZ Rasihashemi, H Sahrai, E Rezazadeh-Gavgani, Y Yazdani, A Khalaji, ... Medical Oncology 39 (12), 183, 2022 | 6 | 2022 |
| Effects of underlying heart failure on outcomes of COVID-19; a systematic review and meta-analysis S Morsali, E Rezazadeh-Gavgani, M Oladghaffari, S Bahramian, ... Romanian Journal of Internal Medicine 61 (1), 6-27, 2023 | 3 | 2023 |
Reza MajidazarTehran University of Medical Sciences在 razi.tums.ac.ir 的电子邮件经过验证
Reza MajidazarTehran University of Medical Sciences在 razi.tums.ac.ir 的电子邮件经过验证
Amirreza NaseriTabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证